BridgeMD
New treatment option for Tooth Extraction
Official title Assessment of the Impact of Neocement Inject P® (Beta-Tricalcium Phosphate) on Bone Volume in Alveolar Ridge Preservation After Tooth Extraction
ClinicalTrials.gov ID: NCT07638319
What this study is testing
- What it's testing
- The goal of this randomized clinical trial is to assess whether β-TCP (Beta-Tricalcium Phosphate) improves alveolar ridge preservation (ARP) in patients who need tooth extraction. The main question it aims to answer is whether using β-TCP for alveolar ridge preservation has a positive effect on bone volume compared with natural healing.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- 18 years or older
- Acceptance of informed consent
- Type 1 or 2 extraction sockets (Elian et al. 2007)
You likely can't join if
- Presence of active infection or severe inflammation in the intervention zone
- Relevant medical history that contraindicates implant surgery
- Patients with poor oral hygiene (full-mouth plaque score and full-mouth bleeding score \>15%) and lack of motivation
- Uncontrolled diabetes (reported levels of glycated haemoglobin exceeding 7%)
- Uncontrolled and /or untreated periodontal disease
- Heavy smokers (more than 10 cigarettes per day)
See the full eligibility criteria
- 18 years or older
- Acceptance of informed consent
- Type 1 or 2 extraction sockets (Elian et al. 2007)
- Presence of active infection or severe inflammation in the intervention zone
- Relevant medical history that contraindicates implant surgery
- Patients with poor oral hygiene (full-mouth plaque score and full-mouth bleeding score \>15%) and lack of motivation
- Uncontrolled diabetes (reported levels of glycated haemoglobin exceeding 7%)
- Uncontrolled and /or untreated periodontal disease
- Heavy smokers (more than 10 cigarettes per day)
- Immunosuppression
The study team makes the final eligibility decision.
Where it's taking place
- Caparica, Monte Da Caparica, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caparica, Monte Da Caparica, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.